HOLLY HEYNE: Open Payments
NPI 1003315789 · ATHOL, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 9 companies in 2025. Trend: 2023 $487 · 2024 $515 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Lilly USA, LLC | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| BETA BIONICS, INC. | 1 | $34 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 1 | $27 |
| Exact Sciences Corporation | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: UBRELVY, TRELEGY ELLIPTA, MOUNJARO, iLet Bionic Pancreas, OTEZLA, PREVNAR 20, The Cologuard Plus Collection Kit, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across ID — which companies pay providers there.
